Skip to content
Screener

ANI Pharmaceuticals ANIP Q1 2025 earnings

Reported May 9, 2025 · Before market open

Revenue$197.1MBeat by $8.4M
EPS$1.70Beat by $0.33
Revenue estimate$188.7M
EPS estimate$1.37

Next report

Nov 6, 2026 (in 2 months)
Revenue estimate$280.1M
EPS estimate$2.12

Financials

Q1 2025

Income statement

See full
Revenue$197.1M+43.4%
Gross profit$124.1M+40.6%
Operating income$26.2M+29.0%
Net income$15.7M-13.9%
EPS (diluted)$0.69-15.9%

Balance sheet

See full
Cash & equivalents$149.8M-34.5%
Total debt$316.5M+10.9%
Total equity$418.6M-7.4%
Total assets$1.3B+41.3%

Cash flow

See full
Operating cash flow$35.0M+91.5%
CapEx$2.5M-46.0%
Free cash flow$32.5M+138%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$1.46B0.0%
Enterprise value$1.62B+7.3%
P/S2.2×-0.7×

Profitability

See full
Gross margin59.3%-3.4pp
Net margin-3.1%-10.0pp
FCF margin9.9%-10.4pp

Returns & leverage

See full
Return on equity-4.8%-14.1pp
Debt / equity0.8×+0.1×
Current ratio2.7×-1.3×

Segments

By product

See full
Generic pharmaceutical products$98.7M+40.5%
Cortrophin Gel$52.9M—
Brands$25.1M—
ILUVIEN and YUTIQ$16.1M—

By segment

See full
Generics and Other$103.0M—
Rare Disease and Brands$94.1M—

FAQ

When did ANI Pharmaceuticals report Q1 2025 earnings?
ANI Pharmaceuticals (ANIP) reported Q1 2025 earnings on May 9, 2025 before market open.
What were ANI Pharmaceuticals's Q1 2025 revenue and EPS?
ANI Pharmaceuticals reported revenue of $197.1M and eps of $1.70 for Q1 2025.
Did ANI Pharmaceuticals beat estimates in Q1 2025?
Revenue beat the consensus estimate of $188.7M by $8.4M. EPS beat the consensus estimate of $1.37 by $0.33.
How did ANI Pharmaceuticals's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 43.4% from $137.4M a year earlier and eps grew 40.5% from $1.21.
Where can I find ANI Pharmaceuticals's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001104659-25-045937) and the 10-Q periodic report (0001023024-25-000046) directly on SEC EDGAR. The filing index links above go to sec.gov.